Drug · DIN 02561395 · Veterinary
EMAVERT TABLETS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 3, 2026; first marketed April 3, 2026.
- Drug Identification Number (DIN)
- 02561395
- Company (DIN owner)
- Felix Pharmaceuticals Pvt. Ltd.Dublin 1, Ireland
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Class
- Veterinary
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MAROPITANT (MAROPITANT CITRATE) | 160 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 1, 2025: NOC 36086Abbreviated New Drug Submission (ANDS) · Administrative – Additional product name
Other DINs named EMAVERT TABLETS
- DIN 02561360 · Marketed
- DIN 02561379 · Marketed
- DIN 02561387 · Marketed